Literature DB >> 14596918

Proteasome-dependent decrease in Akt by growth factors in vascular smooth muscle cells.

Mayumi Adachi1, Koichi Ricardo Katsumura, Kozo Fujii, Sei Kobayashi, Hiroki Aoki, Masunori Matsuzaki.   

Abstract

Akt is activated by growth factors to regulate various aspects of vascular smooth muscle cell function. Platelet-derived growth factor (PDGF) and insulin-like growth factor-1 activated Akt in vascular smooth muscle cells with a rapid reduction of total Akt protein that lasted for several hours. The downregulation of Akt required phosphatidylinositol 3-kinase activity, but not intrinsic Akt activity. The downregulation of Akt was abrogated by MG-132, a proteasome inhibitor, but not by inhibitors of calpain or cathepsins. Akt was found in ubiquitin immune complex after PDGF treatment. Proteasome-dependent degradation of Akt may provide a counter-regulatory mechanism against overactivation of Akt.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596918     DOI: 10.1016/s0014-5793(03)01109-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

2.  Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.

Authors:  Ioannis A Voutsadakis; Anna Patrikidou; Konstantinos Tsapakidis; Aristea Karagiannaki; Eleana Hatzidaki; Nikolaos E Stathakis; Christos N Papandreou
Journal:  Int J Colorectal Dis       Date:  2010-04-16       Impact factor: 2.571

3.  Activation of Akt, not connexin 43 protein ubiquitination, regulates gap junction stability.

Authors:  Clarence A Dunn; Vivian Su; Alan F Lau; Paul D Lampe
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

4.  Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer.

Authors:  Ioannis A Voutsadakis
Journal:  World J Gastrointest Oncol       Date:  2010-05-15

5.  mTOR complex 2 targets Akt for proteasomal degradation via phosphorylation at the hydrophobic motif.

Authors:  You-Tong Wu; Weiming Ouyang; Adam S Lazorchak; Dou Liu; Han-Ming Shen; Bing Su
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

6.  Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein.

Authors:  Mathew A Cherian; Hicham H Baydoun; Jacob Al-Saleem; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Patrick Green; Lee Ratner
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

7.  Oxidative inactivation of the proteasome in retinal pigment epithelial cells. A potential link between oxidative stress and up-regulation of interleukin-8.

Authors:  Alexandre F Fernandes; Jilin Zhou; Xinyu Zhang; Qingning Bian; Janet Sparrow; Allen Taylor; Paulo Pereira; Fu Shang
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

8.  Stimulation of Akt poly-ubiquitination and proteasomal degradation in P388D1 cells by 7-ketocholesterol and 25-hydroxycholesterol.

Authors:  June Liu; Courtney Netherland; Theresa Pickle; Michael S Sinensky; Douglas P Thewke
Journal:  Arch Biochem Biophys       Date:  2009-05-21       Impact factor: 4.013

Review 9.  The ubiquitin-proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer.

Authors:  Ioannis A Voutsadakis
Journal:  J Biomed Sci       Date:  2012-07-24       Impact factor: 8.410

10.  Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer.

Authors:  Athina Stravodimou; Gianluigi Mazzoccoli; Ioannis A Voutsadakis
Journal:  PPAR Res       Date:  2012-09-19       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.